GAMMA Investing’s Cellectis CLLS Stock Holding History

GAMMA Investing’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39K	Sell	463 -271	-37%	-$963	﹤0.01%	3802
2026 Q1	$2.33K	Sell	734 -373	-34%	-$1.43K	﹤0.01%	3624
2025 Q4	$5.36K	Buy	+1,107	New	+$4.63K	﹤0.01%	3246

Other funds holding CLLS

PIS

POM Investment Strategies Raleigh, North Carolina $88.3M AUM 14.86% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

GAMMA Investing's CLLS Position: Q2 2026 in Review

GAMMA Investing reduced its Cellectis (CLLS) stake by 37% in Q2 2026, selling an estimated $963 and leaving 463 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #3802.

GAMMA Investing first reported a position in CLLS in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.36K in Q4 2025. 3 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

GAMMA Investing held 463 shares of Cellectis worth $1.39K as of Q2 2026.
GAMMA Investing sold 271 Cellectis shares in Q2 2026, an estimated $963.
Cellectis made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3802 holding.
GAMMA Investing first reported a position in Cellectis in Q4 2025 and has held it in 3 quarters since.
GAMMA Investing's Cellectis position peaked at $5.36K in Q4 2025.
3 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.